Michael T. Lu, MD, MPH, is Director of AI and Co-Director of the MGH Cardiovascular Imaging Research Center (CIRC), Director of the MGH Imaging Trials Center (MITC), Associate Chair of Imaging Science for the MGH Department of Radiology, and Associate Professor of Radiology at Harvard Medical School.

Dr. Lu's clinical expertise is in cardiovascular imaging, including the acquisition and interpretation of CT, MRI, and ultrasound of the heart and blood vessels.

His research focus is on A) clinical trials of cardiac CT to improve health and B) machine learning to predict health outcomes from multimodal imaging. He is Co-PI of the Data Coordinating Center (DCC) of the REPRIEVE trial, a NHLBI/NIH-sponsored multicenter randomized controlled trial of statins to reduce coronary plaque and prevent cardiovascular events in persons with HIV. Recent work has explored convolutional neural networks to predict long-term mortality, incident lung cancer, and longevity from chest radiograph (x-ray) images and to automate coronary artery calcium scoring on chest CT.

Dr. Lu earned his undergraduate, MD, and MPH degrees from Harvard University.  His training included a transitional internship in Surgery and Medicine at Newton-Wellesley Hospital, residency in Diagnostic Radiology at the University of California, San Francisco, fellowship in Thoracic and Cardiac Imaging at MGH, and a NIH T32 fellowship in Cardiac Imaging at MGH.